TAF II p18 Activators
TAF II p18 Activators encompass a diverse group of chemical compounds that indirectly enhance the functional activity of TAF II p18 through their influence on cellular signaling pathways and transcriptional mechanisms. Forskolin and Rolipram, by increasing intracellular cAMP levels, activate protein kinase A (PKA), which may phosphorylate transcription factors and coactivators associated with the TFIID complex, thereby potentially enhancing TAF II p18's role in transcription initiation. Ionomycin and PMA operate through distinct pathways; the former increases intracellular calcium to activate calcium-dependent kinases, while the latter stimulates protein kinase C (PKC), both of whichcould lead to post-translational modifications that indirectly elevate TAF II p18 activity in the transcription initiation complex. Similarly, EGCG and Retinoic Acid might respectively modify kinase activity or induce expression of genes coding for proteins that synergize with TAF II p18, facilitating its function within TFIID.
The molecular landscape influencing TAF II p18 is further shaped by agents such as Spermidine and Trichostatin A (TSA), which modulate chromatin architecture, making it more conducive to transcriptional activation by the TFIID complex. Spermidine enhances chromatin remodeling, while TSA inhibits histone deacetylases, promoting a transcription-friendly chromatin state. Moreover, agents like 5-Azacytidine and Resveratrol act on epigenetic levels; the former reduces DNA methylation, and the latter activates sirtuins, which may create a chromatin environment that augments TAF II p18's transcriptional activity. Sodium Butyrate, another HDAC inhibitor, along with the cofactor activity of Zn2+ ions, further refines the transcriptional regulation landscape by potentially improving the recruitment and stability of TAF II p18 within the TFIID complex, thereby enhancing gene expression regulation orchestrated by TAF II p18.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can lead to the activation of PKA. PKA can phosphorylate various transcription factors and coactivators, potentially enhancing the transcriptional activity of TAF4B as part of the TFIID complex. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase-4, leading to an increase in cAMP levels, similarly resulting in the activation of PKA. This could enhance TAF4B-mediated transcription by modifying the phosphorylation status of components in the TFIID complex. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent protein kinases. These kinases may indirectly enhance the activity of TAF4B by affecting its protein interactions or stability. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate regulatory proteins involved in transcription. PKC-mediated signaling may enhance TAF4B's role in the assembly or function of the TFIID complex. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate has been shown to modulate various signaling pathways and may have a role in the phosphorylation of transcription factors or coactivators that interact with TAF4B, potentially enhancing its transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts as a ligand for nuclear receptors which can regulate gene expression. It may enhance TAF4B activity by inducing the expression of genes that code for coactivators or other proteins that synergize with the TFIID complex. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine is involved in the process of chromatin remodeling, which is crucial for transcription initiation. It could enhance TAF4B activity by facilitating more accessible chromatin states for transcriptional activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is an inhibitor of histone deacetylases (HDAC), leading to a more relaxed chromatin structure and potentially increasing access of TAF4B and the TFIID complex to DNA, thereby enhancing transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, leading to reduced DNA methylation and potentially enhancing the expression of genes that interact or coactivate with TAF4B. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences multiple signaling pathways, including the activation of sirtuins which have deacetylase activity. This could indirectly enhance TAF4B activity by modifying the acetylation state of histones or transcription factors. | ||||||